Glutaminergic responses of neuropile glial cells and Retzius neurones in the leech central nervous system.
Research article published in Brain research (1990)
Abstract
The effects of glutaminergic agonists on neuropile glial cells and on Retzius neurones in the central nervous system (CNS) of the leech, Hirudo medicinalis were investigated using double-barrelled ion-sensitive microelectrodes. In both types of cells, bath-application of L-glutamate (Glu), kainate (Ka) and quisqualate (Qui) elicited substantial membrane depolarizations which were accompanied by increases of the intracellular Na+ activity aiNa and by concomitant decrease of the intracellular K+ activity aiK. In the glial cells, these alterations of aiNa and aiK were preceded by a transient decrease of aiNa and an increase of aiK upon administration of Ka and Qui. In both glial cells and neurones, N-methyl-D-aspartate (NMDA) did not affect Em, aiK and aiNa. As found for Ka, the neuronal as well as the glial responses to glutaminergic agonists persisted during inhibition of synaptic transmission in high Mg2+, low Ca2+ solutions. The results indicate that leech neuropile glial cells have a Ka/Qui-preferring non-NMDA glutamate receptor similar to that in the Retzius neurones.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
The effects of glutaminergic agonists on neuropile glial cells and on Retzius neurones in the central nervous system (CNS) of the leech, Hirudo medicinalis were investigated using double-barrelled ion-sensitive microelectrodes. In both types of cells, bath-application of L-glutamate (Glu), kainate...
Warum dies für die Hirudotherapie relevant ist
Diese In-vitro-Elektrophysiologie-Studie verwendete doppelläufige ionensensitive Mikroelektroden, um glutamaterge Reaktionen in Neuropil-Gliazellen und Retzius-Neuronen des ZNS von Hirudo medicinalis zu charakterisieren, und stellte fest, dass beide Zelltypen Kainat/Quisqualat-präferenzierende Non-NMDA-Glutamatrezeptoren exprimieren und dass NMDA keine Wirkung zeigte. Die Befunde definieren die grundlegende Neurotransmitter-Rezeptor-Pharmakologie in neuronalen und glialen Zellen des Blutegels. Für den ASH-Bereich handelt es sich um grundlegende Neurobiologie des Blutegels ohne direkte Relevanz für die Hirudotherapie oder das Speichelsekretom; die Relevanz beschränkt sich auf das Verständnis der zellulären Physiologie des Blutegels selbst.
Zitation
Glutaminergic responses of neuropile glial cells and Retzius neurones in the leech central nervous system.
Dörner et al. · Brain research, 1990
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: May 28, 2026 · Letzte Aktualisierung der Website: 18. Juni 2026